Home / Auditor changes / CTT PHARMACEUTICAL HOLDINGS, INC.
Filed 2026-10-09 路 Form 8-K 路 Accession 0001477932-26-006156 nano
Price before filing: $0.0566 (2026-10-08 close, split/dividend-adjusted)
Market cap at flag: $3.4M (2026-10-09) 路 Latest: $3.5M (2026-10-16)
| Window | CTTH | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | pending | pending | until 2026-11-08 | |
| 90 days | pending | pending | until 2027-01-07 | |
| 180 days | pending | pending | until 2027-04-07 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: 1 insider bought $4K (13 purchases)
30 days after (window still open until 2026-11-08): none reported so far.
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-07 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | 7,700 | $0.07 | $500 | no | Form 4 |
| 2026-08-14 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | 1,800 | $0.06 | $112 | no | Form 4 |
| 2026-08-19 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | 10,000 | $0.06 | $590 | no | Form 4 |
| 2026-08-20 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | 11,500 | $0.04 | $518 | no | Form 4 |
| 2026-08-24 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | 2,100 | $0.06 | $116 | no | Form 4 |
| 2026-08-31 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | 3,500 | $0.05 | $172 | no | Form 4 |
| 2026-09-02 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | 3,000 | $0.05 | $147 | no | Form 4 |
| 2026-09-04 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | 9,800 | $0.05 | $479 | no | Form 4 |
| 2026-09-10 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | 3,500 | $0.05 | $175 | no | Form 4 |
| 2026-09-16 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO, Director | Purchase | 10,900 | $0.05 | $523 | no | Form 4 |
| 2026-09-22 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO, Director | Purchase | 10,100 | $0.04 | $454 | no | Form 4/A |
| 2026-09-28 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO, Director | Purchase | 3,400 | $0.06 | $187 | no | Form 4 |
| 2026-10-06 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO, Director | Purchase | 3,700 | $0.06 | $204 | no | Form 4 |
| 2026-10-09: red flag filed | |||||||
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2026-07-11 to 2026-11-08. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
The company changed its outside auditor (8-K Item 4.01). A dismissal or resignation, especially near an annual report or with reported disagreements, is a warning sign. Changes caused by audit firms merging are usually routine.
Type: changed
Disagreements reported: no
Why this score: also within 90 days: Going-concern doubt
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.